^○Masanari ITOKAWA^{1, 2} (1. Tokyo Metropolitan Institute of Medical Science, 2. Tokyo Metropolitan Matsuzawa Hospital)

^○Haruhide KIMURA (Neuroscience Drug Discovery Unit, Research, Takeda Parmaceutical Company Limited)

^○Kazuki YABUUCHI¹, Kenneth KOBLAN², Robert GOLDMAN², Justine KENT², Seth HOPKINS², Antony LOBEL² (1. Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan, 2. Sunovion Pharmaceutical Inc.)

^○Hidenori YAMASUE (Department of Psychiatry, Hamamatsu University School of Medicine)

^○Toshihiko MATSUMOTO¹, Hiroko KOTAJIMA-MURAKAMI^{1, 2}, Ayumi TAKANO³, Yasukazu OGAI⁴, Daisuke FUNADA^{1, 5}, Yuko TANIBUCHI^{1, 6}, Hisateru TACHIMORI⁷, Kazushi MARUO⁸, Kazutaka IKEDA^{1, 2} (1. Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, 2. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 3. Department of Mental Health and Psychiatric Nursing Tokyo Medical and Dental University, 4. Social Psychiatry and Mental Health, Faculty of Medicine, University of Tsukuba, 5. Department of Psychiatry, Center Hospital, National Center of Neurology and Psychiatry, 6. Department of Psychiatry, Chiba Hospital, 7. Department of Clinical Research Promotion, Transrational Medical Center, National Center of Neurology and Psychiatry, 8. Department of Biostatistics, Faculty of Medicine, University of Tsukuba)

^○Hiroko ONO¹, Chong ZHANG², Ying XU³, James M O’DONNELL^{2, 3}, Hidekuni YAMAKAWA¹, Naotaka HORIGUCHI¹, Toshiyuki ASAKI¹, Mark E GURNEY⁴ (1. Drug Discovery & Disease Research Laboratory, Shionogi & Co., Ltd., 2. Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, 3. Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, 4. Tetra Discovery Partners Inc.)

^○Eriko NAKATA (Nippon Chemiphar Co., Ltd.)

^○Bjarke EBERT (H. Lundbeck A/S)

^○Shawn K SINGH (VistaGen Therapeutics, Inc.)

^○Yushin TOMINAGA¹, Nagahide TAKAHASHI², Ayako SHIRAISHI¹, Yuka NAMIKAWA¹, Aya YAMADA¹, Yuya YAMADA¹, Toshifusa SHU¹, Hiroko SHIMIZU¹, Peter ZANNIKOS³, Jaskaran SINGH³, David HOUGH³ (1. Janssen Japan R&D, 2. Hamamatsu University School of Medicine, 3. Janssen Research and Development, LLC )

^○Kenji HASHIMOTO (Chiba University Center for Forensic Mental Health, Chiba, Japan)